Multiple Sclerosis (MS) | Norton Healthcare

Indication: Multiple Sclerosis (MS)

An Observational Study Of Ocrelizumab-Treated Patients With Multiple Sclerosis To Determine The Incidence And Mortality Rates Of Breast Cancer And All Malignancies (VERISMO STUDY)

Malignancies following treatment

Observational

Principal Investigator: Geeta Aruna Ganesh, M.D.
Norton Neuroscience Institute

Sponsor: F. Hoffmann-LaRoche Ltd.

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.